Skip to Content
Merck
All Photos(1)

Documents

G006121

HPLC Analysis of Recombinant Tumor Necrosis Factor Receptor-Fc Fusion Protein (rhTNFR-Fc) on Zenix® SEC-300 versus SRT® SEC-300, Effect of Particle Size on Resolution

application for HPLC

Sign Into View Organizational & Contract Pricing


About This Item

technique(s)

HPLC: suitable

test parameters

column: Zenix SEC-300, 30 cm x 7.8 mm I.D., 3 μm, 300 Å particles (Z777051)
column: SRT SEC-300, 30 cm x 7.8 mm I.D., 5 μm, 300 Å particles (Z777051) (Z777033)
mobile phase: 150 mM sodium phosphate, pH 7.0
flow rate: 1 mL/min
detector: UV, 214 nm
injection: 20 μL
sample: Recombinant tumor necrosis factor receptor-Fc fusion protein (rhTNFR-Fc), including oligomers (440 kD and 360 kD), monomer (150 kD), and impurity (120 kD)

suitability

application for HPLC

application(s)

life science and biopharma
pharmaceutical (small molecule)

Legal Information

SRT is a registered trademark of Sepax Technologies
Zenix is a registered trademark of Sepax Technologies

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service